3M FY2026 Q3 Earnings: $2.63 EPS (+70%) on a $281M Solventum Gain — While Operating Cash Fell 72%

3M earned $1.37 billion in the third quarter of 2026, up 65% on $6.58 billion of revenue, and raised its full-year adjusted EPS guide to $9.10–$9.15 — but only $486 million of that profit arrived as operating cash, down 72% from last year, because $1 billion walked out the door to litigation settlements in a single quarter. The industrial turnaround is real; so is the settlement annuity underneath it.

The Headline Numbers​

Every figure below comes from the Form 10-Q and the earnings release filed October 20, 2026.

Net income here is attributable to 3M common shareholders throughout, matching the filing's presentation. Two deltas tell the whole quarter. First, the $539 million jump in net income is dominated by a $375 million year-on-year swing in the value of 3M's retained Solventum stake — a $281 million gain this quarter against a $94 million loss last year — plus the absence of last year's $161 million held-for-sale charge. Second, operating cash flow collapsed even as earnings soared: 3M made $1 billion of pre-tax litigation and PFAS-exit payments in the quarter against net receipts of $32 million a year ago. GAAP free cash flow (operating cash less $256 million of capex) printed $230 million, a 3.5% margin against 23.6% last year. On the adjusted basis management prefers — which adds back those settlement payments — free cash flow was $1,197 million, down a far gentler 9%, for an 18.2% margin against 20.7%. Which margin you quote depends on whether you think $1 billion quarterly settlement checks are a cost of doing business. They are, through 2029 at least.

Revenue Deep Dive​

Management's own summary of the quarter's demand picture is worth quoting verbatim: "Net sales change was driven by strength in industrial, safety, semiconductor and data center — supported by commercial excellence and innovation — and activity from the July 2026 acquisition of Madison Fire and Safety" (10-Q, MD&A Overview). The segment detail confirms it. Safety and Industrial is the thesis working: organic sales rose in every division except roofing granules — "electrical markets, fire safety, industrial adhesives and tapes, personal safety, automotive aftermarket, abrasives and industrial specialties" — and segment operating income jumped 21% to a 30.1% margin, up three full points. The Madison acquisition added roughly $90 million of sales and 3.1 points of inorganic growth to the segment.

Transportation and Electronics is the split screen: "strength in semiconductor, aerospace, data center, advanced materials, and commercial branding, partially offset by weakness in consumer electronics and auto." Organic growth of 0.5% with a margin that slipped a point to 23.4% on growth investments and PFAS-exit dis-synergies. Consumer shrank again — organic −0.2% — with a memorably commercial explanation: "Lower U.S. retailer inventory levels more than offset positive POS and share gains." 3M is winning at the shelf and losing in the stockroom. And Corporate sales fell by two-thirds to $96 million because manufactured PFAS products, which 3M finished exiting at the end of 2025, contributed nothing this quarter against $199 million a year ago — the reason adjusted organic growth (3.3%) so exceeds the GAAP 0.2%.

Geography sharpened the divide: the Americas grew 4.4% organically while Asia Pacific fell 6.2%, with China down 10.7% organically on the quarter. Absent from the release and the MD&A is any claim that demand exceeds supply, that supply is tight, or that 3M is capacity-constrained anywhere — after a quarter of genuine industrial strength, management is describing share gains and productivity, not an upcycle it cannot feed. That restraint is a finding in itself.

The Margin Story​

Gross margin hit 42.3%, the best in this ledger's history, and the mechanics are unusually legible: "procurement savings, manufacturing and logistics productivity initiatives, and pricing actions offsetting oil price headwinds, partially offset by PFAS exit-related costs and material inflation." That pricing clause is the quarter's quiet pricing-power signal — 3M pushed price through while input costs rose. GAAP operating margin gained 150 basis points to 23.7% mostly on mix of special items (no repeat of last year's $161 million held-for-sale charge), while the adjusted margin's 110-point gain to 26.2% reflects the cleaner drivers management cites across every segment: "benefits from growth and productivity, partially offset by tariff impacts, cost dis-synergies (following the exit of PFAS manufacturing and the 2024 spin of Solventum), and growth investments."

The nine-month view disciplines the celebration: GAAP operating margin is 20.6%, up only 20 basis points, because the first half carried $343 million of divestiture losses (led by Dyneon's $324 million) and $224 million of transformation costs. The margin expansion is real but back-half loaded, and it leans on classifications — starting this quarter, 3M moved acquired-intangible amortization into Corporate special items and out of segment profit for all periods presented, flattering every segment margin retroactively. Watch the adjusted definition, not just the adjusted number.

The One Big Question: The $18.5 Billion Annuity Under the Turnaround​

3M will pay up to $12.5 billion to resolve public-water-supplier PFAS claims from 2024 through 2036, and $6.0 billion to resolve Combat Arms earplug claims from 2023 through 2029 — up to $18.5 billion combined, of which $8.2 billion was already paid through the end of 2025. Every quarter from here is a race between the industrial recovery and that payment schedule, so the right way to read this quarter is as a bridge:

Two lines deserve scrutiny. The $0.60 Solventum swing is mark-to-market noise on a $2.3 billion stake 3M must sell within five years of the 2024 spin — real value, but it has nothing to do with selling abrasives. More structurally, the "net costs for significant litigation" add-back is becoming a permanent feature of adjusted earnings: $99 million after tax this quarter, $311 million in nine months, $1,052 million in full-year 2025. When a company adjusts out nine-figure litigation costs every single quarter, the adjustment is the business model, not the exception.

The balance sheet shows where the race stands. Total equity is $4.2 billion against $34.4 billion of liabilities — thin because $38.1 billion of buybacks sit in treasury stock and $6.8 billion of settlement-era losses flowed through retained earnings and AOCI. And 3M keeps returning cash as though the annuity did not exist: $3.2 billion of buybacks plus $1.2 billion of dividends in nine months, funded partly by new debt — €1.5 billion of September notes and a $1.43 billion term loan for Madison. Net settlement payments are at least declining: $2.0 billion pre-tax in nine months against $3.3 billion last year, helped by insurance recoveries. The question for 2027 is whether that decline continues faster than the buyback authorization ($1.5 billion left of $7.5 billion) runs out.

Tracking a $39.5 Billion Company in Plain Text​

Double-entry bookkeeping forces every number to reconcile, which makes it the ideal medium for a company whose story is the gap between earnings and cash. Our ledger models 3M exactly how we model every company: one zero-sum income transaction per period, balance-sheet assertions that tie to the filed totals. History starts at FY2023 because no filing restates the 2021–2022 balance sheets without the spun-off Solventum business. Here is the quarter just reported, straight from the ledger (income is negative because it is a credit; expenses are positive):

; FY2026Q3 Income Statement — three months ended September 30, 2026
; Check: −6,584 + 3,801 + 921 + 304 + (−112) + 261 + (−1) + 37 + 1,373 = 0 ✓
; No loss on business divestitures this quarter. Other income of 112 is the
; $281M Solventum-stake gain less $217M of interest expense and other items
; (Note 6). The 37 combines $4M of nonredeemable NCI income with the $41M
; redeemable-NCI redemption adjustment less the venture's $8M share of
; losses (Note 8); the offset is net income attributable to 3M.
 
2026-09-30 * "3M Company" "FY2026Q3 Income Statement"
  Income:Revenue                              -6584 MUSD  ; net sales
  Expenses:CostOfRevenue                        3801 MUSD  ; cost of sales
  Expenses:SellingGeneralAdministrative           921 MUSD  ; selling, general and administrative expenses
  Expenses:ResearchAndDevelopment                 304 MUSD  ; research, development and related expenses
  Income:OtherNet                                 -112 MUSD  ; other expense (income), net — income this quarter (incl. the $281M Solventum-stake gain, Note 6)
  Expenses:IncomeTax                               261 MUSD  ; provision for income taxes
  Income:OtherNet                                    -1 MUSD  ; income from unconsolidated subsidiaries, net of taxes
  Expenses:OtherNet                                  37 MUSD  ; net income attributable to NCIs and adjustment to redeemable NCI, deducted as the filing does
  Equity:Adjustments                               1373 MUSD  ; net income attributable to 3M common shareholders offset (RE set by balance assertion)

Note the two Income:OtherNet postings: the $112 million of other income and the $1 million from unconsolidated subsidiaries are kept on separate lines so each ties to its own face-statement caption, and the $37 million NCI deduction sits in Expenses:OtherNet exactly as the filing deducts it before the attributable line. The one balance-sheet number that tells the narrative is treasury stock: $38.1 billion at cost, nine times total equity of $4.2 billion. 3M has bought back so much of itself — 427 million shares in the treasury against 517 million outstanding — that the balance sheet is essentially a call option on the operating business plus a $2.3 billion Solventum stub, which at 55% of equity is itself the second-largest swing factor in book value. Every per-share number in this post is flattered by a share count down 3% year-on-year and over 5% since the spin.

The Multi-Year Arc​

(Q3 2026 column is the quarter, not annualized — it is shown for margin comparison, not scale.)

Read the arc in three acts. Act one, 2023: the reckoning — a $10.3 billion PWS charge and a $4.2 billion Combat Arms charge inside SG&A produced a $7.0 billion attributable loss, the reason this ledger's first year prints red. Act two, 2024–2025: the cleanup — Solventum spun off, PFAS manufacturing exited, the dividend rebased from $6.00 to $2.92, and operating cash flow finding a floor around $2 billion against $3-billion-plus annual settlement outflows. Act three, now: the pivot to growth — Safety and Industrial compounding at 7% organic with 30% margins, a $1.9 billion Madison acquisition folded into a Bain-backed venture, and, the day before earnings, a warrant deal with Amazon that vests 3.2 million shares against $6 billion of cumulative data-center product sales. Revenue has been flat at $24.6–$24.9 billion for three years; everything shareholders have earned came from margins, buybacks, and multiple repair. The Amazon vesting schedule — $6 billion of optical-connectivity sales over seven years — is the first concrete evidence of where the next revenue leg comes from.

The Verdict: Bull vs. Bear​

Bull Case

• Safety and Industrial is a 30%-margin compounder at scale: $3.18 billion of quarterly sales growing 7% organically across every division but one, with Madison adding a fire-safety leg Bain was willing to co-invest $1.3 billion behind.
• Data center is becoming a second growth engine with a signed customer: the Amazon warrant vests on $6 billion of cumulative optical-connectivity sales, and management cites data-center strength in both industrial segments.
• The guide raise is specific and large: adjusted EPS $9.10–$9.15 against $7.11 earned in nine months implies roughly $1.99–$2.04 in Q4 on the new amortization-excluded basis, with adjusted operating cash flow of ~$5.9 billion backing it.
• Settlement cash is past its peak: nine-month pre-tax litigation payments of $2.0 billion versus $3.3 billion last year, with insurance recoveries now flowing — every dollar of decline drops nearly straight to free cash flow.
• The share count does quiet work: diluted shares down 2.9% year-on-year to 522.6 million, mechanically adding three points to every per-share growth rate in this post.

Bear Case

• GAAP free cash flow was $230 million on $6.58 billion of sales — a 3.5% margin, down from 23.6% — and management still called it "robust free cash flow." The settlement payments the adjusted metrics exclude are senior to shareholders.
• Two of three segments are stagnant: Transportation and Electronics grew 0.5% organically with a falling margin, Consumer shrank 0.2% organically, and China fell 10.7% — the quarter is a one-segment story.
• Up to $10 billion of settlement payments remain (roughly $12.5 billion PWS + $6.0 billion CAE, less $8.2 billion paid), running through 2036 — a decade-long prior claim that caps leverage to the upside.
• The $2.3 billion Solventum stub is 55% of book equity and pure mark-to-market: a 20% Solventum drawdown erases $460 million of "other income" the P&L has been counting as earnings power.
• Debt is rising to fund shareholder returns, not just growth: €1.5 billion of new notes plus a $1.43 billion term loan while $4.4 billion went to buybacks and dividends in nine months — against $2.0 billion of operating cash.

Our Take

3M is executing the industrial turnaround well and financing it recklessly — but at 30% segment margins with settlement outflows finally declining, execution matters more than financing. The Amazon data-center validation, the raised guide, and the back-half margin ramp outweigh a quarterly cash trough that was telegraphed by the payment schedule. The bull case wins on a two-year view, provided you underwrite the settlement annuity as a known coupon rather than pretending the adjusted numbers are the real ones. This is a compounding industrial with a litigation mortgage, priced accordingly — buy the compounder, discount the mortgage, and never annualize a Solventum quarter.